Chlamydia pneumoniae infection related atherosclerotic clinical variables on carotid stenosis

Journal of Clinical Neuroscience

Volumn 11, Issue 4, 2004, Pages 389-394

  Colpan, Mustafa Efkan ^a   Attar, Ayhan ^a   Colpan, Aylin ^b   Karahan, Ceren ^b   Seckin, Selda ^b   Sargons, Mustafa Fevzi ^c   Egemen, Nihat ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b ANKARA NUMUNE HOSPITAL   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Aetiology; Atherosclerosis; Carotid stenosis; Chlamydia pneumoniae

Indexed keywords

CHOLESTEROL; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOGRAPHY; ANTIBODY TITER; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CALCIFICATION; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOCYTOCHEMISTRY; INCIDENCE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REINFECTION; SMOKING; STROKE; SYMPTOMATOLOGY; TRANSIENT ISCHEMIC ATTACK;

EID: 2342456918     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(03)00153-X     Document Type: Article

References (26)

1. Ophuls W. Artherosclerosis and cardiovascular disease. JAMA 1921; 76: 700-701.
2. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus induced atherosclerosis. J Exp Med 1978; 148: 335-340.
3. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997; 96: 2144-2148.
4. Jackson LA, Campbell LA, Kuo C, Rodriquez DI, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. JID 1997; 176: 292-295.
5. Krüll M, Klucken AC, Wuppermann FN, Fuhrmann O, Magerl C, Seybold J, Hippenstiel S, Heggemann JH, Jantos CA, Suttorp N. Signal transduction pathway activated in endothelial cells following infection with Chlamydia pneumoniae. J Immunol 1999; 162: 4834-4841.
6. Schussheim AE, Fuster V. Antibiotics for myocardial infection. Drugs 1999; 57(3): 283-291.
7. Tangirala RK, Rubin EM, Palinski W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res 1995; 36: 2320-2328.
8. Wong YK, Gallagher PJ, Ward ME. Chlamydia pneumoniae and atherosclerosis. Heart 1999; 81: 232-238.
9. Moazed TC, Kuo CC, Grayston JT, Campbell LA. Evidence systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 1998; 177: 1322.
10. Gaydos CA, Pham DG, Quinn TC. Chlamydia pneumoniae infections in macrophages and coronary artery endothelial cells. In: Proceedings Third Meeting of the European Society for Chlamydia Research. Vol: 3A. strayed. Societal Editrice Esculapio, Bologna; p.89.
11. Epstein SE, Speir E, Zou YF, Guetta E, Leon M, Finkel T. The role of infection in re-stenosis and atherosclerosis: focus on cytomegalovirus. Lancet 1978; 348: 513-517.
12. Wang P, Ba ZF, Chaudry IH. Administration of tumor necrosis factor α in vivo depresses endothelium-dependent relaxation. Am J Physiol 1994; 266: H2535-H2541.
13. Sammalkorpi K, Valtonen V, Kerttula Y, Nikkila E, Taskinen MR. Changes in serum lipoprotein pattern induced by acute infections. Metabolism 1988; 37: 859-865.
14. Woordhouse PR, Khaw KT, Plummer M, Foley A, Meade TW. Seasonal variation of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet 1994; 343: 435-439.
15. Mayr M, Metzler B, Keichl S, Willeit J, Schett G, Xu Q, Wick G. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae. Circilation 1999; 99: 1560-1566.
16. Gupta S, Camm AJ. Chlamydia pneumoniae, antimicrobial therapy and coronary heart disease: a critical overview. Coron Atery Dis 1998; 9(6): 339-343.
17. Gupta S, Camm AJ. Is there infective etiology to atherosclerosis. Drugs Aging 1998; 13(1): 1-7.
18. Hu H, Pierce GH, Zhong G. The atherogenic effects of Chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 1999; 103: 747-753.
19. Nyström-Rosander C, Thelin S, Hjelm E, Lindquist O, Pahlson C, Friman G. High incidence of Chlamydia pneumoniae in sclerotic heart valves of patients undergoing aortic valve replacement. Scan J Infect Dis 1997; 29: 361-365.
20. Wimmer MLJ, Sandmann-Strupp R, Saikku P, Haberl RL. Association of Chlamydial infection with cerebrovascular disease. Stroke 1996; 27: 2207-2210.
21. Johnson WD, Moses J, Kipshidze NW. Absence of Chlamydia pneumoniae in surgical specimens of coronary and carotid arteries by polymerase chain reaction. Cardiovasc Radiat Med 2001; 2(4): 221-224.
22. Hirashima Y, Kuwayama N, Kubo M, Origasa H, Endo S. Chlamydia pneumoniae infection is not involved in carotid artery stenosis. Atherosclerosis 2002; 163(1): 165-168.
23. Halme S, Surcel HM. Cell mediated immunity to Chlamydia pneumoniae. Scan J Infect Dis Suppl 1997; 104: 18-21.
24. Vainas T, Kurvers HAJM, Mess MH, Graaf R, Ezzahiri R, Schurink GWH, Bruggeman CA, Kitslar PJEHM. Chlamydiae pneumoniae serology is associated with thrombosis-related but not with plaque-related microembolization during carotid endarterectomy. Stroke 2002; 33: 1249-1254.
25. Beadenkopf WG, Deoud AS, Love BM. Calcification in the coronary arteries and relationship to arteriosclerosis and myocardial infarction. Am J Roentgenol 1964; 92: 865-871.
26. Matsushita M, Nishikimi N, Sakurai T, Nimura Y. Relationship between aortic calcification and atherosclerotic disease in patients with abdominal aortic aneurysm. Int Angiol 2000; 19(3): 276-279.